(4S)-6-CHLORO-4-((E)-2-CYCLOPROPYLVINYL)-4-(TRIFLUOROMETHYL)-3,4-DIHYDROQUINAZOLIN-2(1H)-ONE
| Title | Journal |
|---|---|
| Hybrid diarylbenzopyrimidine non-nucleoside reverse transcriptase inhibitors as promising new leads for improved anti-HIV-1 chemotherapy. | Bioorganic & medicinal chemistry 20100715 |
| QSAR for non-nucleoside inhibitors of HIV-1 reverse transcriptase. | Bioorganic & medicinal chemistry 20060901 |
| Recent advances in the development of next generation non-nucleoside reverse transcriptase inhibitors. | Current topics in medicinal chemistry 20040101 |
| General scope of 1,4-diastereoselective additions to a 2(3H)-quinazolinone: practical preparation of HIV therapeutics. | The Journal of organic chemistry 20030207 |
| Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors. | Antimicrobial agents and chemotherapy 20020601 |
| DPC-083. DuPont Pharmaceuticals. | Current opinion in investigational drugs (London, England : 2000) 20010901 |
| 4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors. | Bioorganic & medicinal chemistry letters 20010604 |
| New antiretroviral agents. | The Hopkins HIV report : a bimonthly newsletter for healthcare providers 20010301 |
| Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase. | Bioorganic & medicinal chemistry letters 20010212 |
| 3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors. | Bioorganic & medicinal chemistry letters 20010122 |
| Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors. | Journal of medicinal chemistry 20000518 |
| Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1. | Antimicrobial agents and chemotherapy 19991201 |